What is it about?
A review proposing a strategic toolbox and preclinical research pathway for inherited orphan diseases. We describe loss of function mutations, gain of function mutations and approaches for addressing each. There is some discussion of computational approaches that have been and could be used for this area.
Featured Image
Why is it important?
Probably the first or an early discussion of such strategies that is comprehensive. It provides comprehensive information useful for funding and patient advocacy groups as well as academic groups and start-up companies.
Perspectives
The review is the result of a workshop meeting held in Toronto in late 2011 that brought together many different groups to discuss "treating inherited rare disorders: choosing the shortest (and most generalizable) paths to the clinic". This was a pivotal meeting for me coming weeks after meeting Jill Wood, a rare disease parent. One of those turning points for me.
Dr Sean Ekins
Collaborations in Chemistry
Read the Original
This page is a summary of: A generalizable pre-clinical research approach for orphan disease therapy, Orphanet Journal of Rare Diseases, June 2012, Springer Science + Business Media,
DOI: 10.1186/1750-1172-7-39.
You can read the full text:
Contributors
The following have contributed to this page
